FDA inspection
Mylan Laboratories Limited: FDA inspection ending Jun 26, 2024
FDA inspection 1242111 · Pithampur, District Dhar
Key facts
| Inspection ID | 1242111 |
|---|---|
| Firm | Mylan Laboratories Limited |
| FEI number | 3010453141 |
| Address | (FDF-3) Plot Nos. 11, 12, 13, Indore SEZ, Pharma Zone, Phase II, Sector III |
| City | Pithampur, District Dhar |
| Fiscal year | 2024 |
| Inspection end date | Jun 26, 2024 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 690897 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data